EligibleTrials

Clinical trials recruiting for Gastric/Gastroesophageal Junction Adenocarcinoma

3
Recruiting trials
7
US states with sites
10
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 1 2Phase 2 2

Drugs and treatments being studied

InterventionTrials
BMS-936558-011
BMS-9863401
Docetaxel1
H2 receptor antagonist1
IBI343,Gemcitabine, Albumin-bound Paclitaxel1
OKN43951
Pembrolizumab1
Pumitamig1

Where trials are recruiting (top US states)

StateRecruiting trials
California2
Texas2
Iowa1
New Jersey1
New York1
Oregon1
Tennessee1

Top cities

Houston, Texas 2Beverly Hills, California 1Clovis, California 1Hackensack, New Jersey 1Iowa City, Iowa 1Los Angeles, California 1Nashville, Tennessee 1New York, New York 1Newport Beach, California 1Portland, Oregon 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Gastric/Gastroesophageal Junction Adenocarcinoma often also study these conditions. Each links to its own recruiting-trial list.

Pancreatic cancer 870Non-small cell lung cancer 507Lung cancer 2180Colorectal cancer 1359Urothelial Carcinoma 29Triple Negative Breast Neoplasms 12Squamous Cell Carcinoma of Head and Neck 11Solid Tumours 4Sarcoma 48Pancreatic Ductal Adenocarcinoma 64

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Gastric/Gastroesophageal Junction Adenocarcinoma trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.